Pasta maker Barilla funds cell therapy research for coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association “The Cure Alliance” to fund research on a COVID-19 therapy based on stem cells, the group said on Monday.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the U.S. Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous 2 million euro ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company’s home country.
Reuters
Related news
Randstad explores the relationship between AI and the world of work
In early February Randstad published the first details of its…
Read more >CETIN Hungary and the University of Pécs enter into cooperation
The independent, integrated telecommunications infrastructure provider CETIN Hungary Zrt. and…
Read more >Health in everyday life
A healthy lifestyle means different things to different people, and…
Read more >Related news
FHA Singapore has opened, six exhibitors at the stand of the Agricultural Marketing Center
One of Asia’s most important international exhibitions, Food and Hotel…
Read more >“I Love Trade Marketing” conference series: Inflation from different perspectives
Held around Valentine’s Day for more than 20 years, the…
Read more >Fruit Logistica attracts industry leaders from around the world
Fruit Logistica, the world’s leading trade fair for the fruit…
Read more >